联影医疗
(688271)
| 流通市值：830.03亿 | | | 总市值：1153.00亿 |
| 流通股本：5.93亿 | | | 总股本：8.24亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,477,948,927.49 | 10,300,104,386.97 | 6,954,283,174.55 | 5,333,486,253.17 |
| 营业收入 | 2,477,948,927.49 | 10,300,104,386.97 | 6,954,283,174.55 | 5,333,486,253.17 |
| 二、营业总成本 | 2,132,796,705.76 | 9,385,271,546.62 | 6,608,289,860.41 | 4,564,826,089.38 |
| 营业成本 | 1,240,455,707.69 | 5,300,161,724.44 | 3,518,012,196.57 | 2,646,865,179.76 |
| 税金及附加 | 14,479,376.59 | 56,781,176.03 | 36,559,730.57 | 27,173,585.08 |
| 销售费用 | 384,106,190.53 | 1,823,187,055.28 | 1,385,289,095.62 | 891,366,003.06 |
| 管理费用 | 131,820,633.48 | 555,965,099.19 | 411,739,490.53 | 238,744,275.5 |
| 研发费用 | 378,872,051.95 | 1,761,466,670.35 | 1,317,598,874.67 | 826,022,924.17 |
| 财务费用 | -16,937,254.48 | -112,290,178.67 | -60,909,527.55 | -65,345,878.19 |
| 其中:利息费用 | 3,378,239.1 | 9,073,217.24 | 5,150,408.19 | 3,420,713.91 |
| 其中:利息收入 | -20,764,111.74 | -116,273,030.76 | -91,794,911.66 | -70,968,434.57 |
| 加:公允价值变动收益 | -38,695,784.91 | 37,000,082.01 | 634,719.17 | 7,410,470.99 |
| 加:投资收益 | 14,529,364.7 | 98,073,989.14 | 72,236,681.41 | 45,034,348.3 |
| 资产处置收益 | - | -869,838.94 | 623,351.82 | 622,909.34 |
| 资产减值损失(新) | -52,668.06 | 13,842,775.25 | 50,456,126.82 | 39,520,280.84 |
| 信用减值损失(新) | -37,982,156.67 | -140,717,437.52 | -107,927,266.45 | -73,491,375.32 |
| 其他收益 | 115,812,587.45 | 444,193,498.96 | 355,172,710.2 | 252,502,221.6 |
| 营业利润平衡项目 | 0 | 0 | -0.01 | 0 |
| 四、营业利润 | 398,763,564.24 | 1,366,355,909.25 | 717,189,637.1 | 1,040,259,019.54 |
| 加:营业外收入 | 591,460.54 | 5,546,317.51 | 3,634,098.03 | 1,551,981.76 |
| 减:营业外支出 | 1,536,564.68 | 20,194,712.78 | 8,963,565.27 | 2,013,184.16 |
| 利润总额平衡项目 | 0 | 0 | 0.01 | 0 |
| 五、利润总额 | 397,818,460.1 | 1,351,707,513.98 | 711,860,169.87 | 1,039,797,817.14 |
| 减:所得税费用 | 32,293,254.84 | 109,783,513.52 | 53,470,659.97 | 95,232,490.9 |
| 六、净利润 | 365,525,205.26 | 1,241,924,000.46 | 658,389,509.9 | 944,565,326.24 |
| 持续经营净利润 | 365,525,205.26 | 1,241,924,000.46 | 658,389,509.9 | 944,565,326.24 |
| 归属于母公司股东的净利润 | 370,082,216.76 | 1,261,869,451.27 | 671,163,083.66 | 950,211,921.88 |
| 少数股东损益 | -4,557,011.5 | -19,945,450.81 | -12,773,573.76 | -5,646,595.64 |
| (一)基本每股收益 | 0.45 | 1.54 | 0.82 | 1.16 |
| (二)稀释每股收益 | 0.45 | 1.54 | 0.82 | 1.16 |
| 八、其他综合收益 | -2,289,461.42 | 6,068,286.44 | -7,857,195.81 | 2,233,137.29 |
| 归属于母公司股东的其他综合收益 | -2,289,461.42 | 6,068,286.44 | -7,857,195.81 | 2,233,137.29 |
| 九、综合收益总额 | 363,235,743.84 | 1,247,992,286.9 | 650,532,314.09 | 946,798,463.53 |
| 归属于母公司股东的综合收益总额 | 367,792,755.34 | 1,267,937,737.71 | 663,305,887.85 | 952,445,059.17 |
| 归属于少数股东的综合收益总额 | -4,557,011.5 | -19,945,450.81 | -12,773,573.76 | -5,646,595.64 |
| 公告日期 | 2025-04-29 | 2025-04-29 | 2024-10-31 | 2024-08-31 |
| 审计意见(境内) | | 标准无保留意见 | | |